Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
CRYSTALLINE FORM OF 1-(4-1-(2,6-DIFLUOROBENZYL)-5-DIMETHYLAMINOMETHYL-3-(6-METHOXYPYRIDAZIN-3-YL)-2,4-DIOXO-1,2,3,4-TETRAHYDROTHIENO(2,3-D)-PYRIMIDIN-6YL)PHENYL)-3-METHOXYUREA

No-Receipt date 2022-01696 - 12/05/2022
No-Filing date 20220400999 - 12/05/2022
No-Granting date 3110316 - 20/05/2022
No-EPO application date 18185835.8 - 27/09/2013
No-EPO granting date 3415517 - 20/04/2022
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 5/2022 - 08/06/2022
Expiration date 28/09/2033
Kind of title Validation of European Patent
Legal status VALID
Priorities JP201221767928/09/2012/JP
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61P 15/08
A61P 5/02
C07D 495/04

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1421735 TAKEDA PHARMACEUTICAL COMPANY LIMITED 1-1, DOSHOMACHI 4-CHOME, CHUO-KU,OSAKA-SHI, OSAKA 541-0045, JAPAN

Inventors
CodeFirstnameSurname
3666736 MIWA, KAZUHIRO
3666737 SASAKI, TSUYOSHI
3666738 KOMURA, FUMIYA

Representatives
CodeFirstnameSurnameAddressTownZip
3712ANTHOULAGALANOPOULOUTHESI LYSI MPITAKOUKAPANDRITI (ATTIKIS)19014

Contact
CodeFirstnameSurnameAddressTownZipCountry
9219ALKISTIS-EIRINIMALAMIVISSARIONOS 3ATHINA (ATTIKIS)10672 GREECE

Owners History

Title Instruments

Payments history 12 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015